TP53 and colorectal cancer: Additional approaches include targeting of endogenous reverse transcriptase activities, as recently shown in colorectal cancer [37] or indeed, somewhat paradoxically (given its role in RE suppression), induction of p53 that triggers the viral mimicry response by allowing p53 to bind and activate a subset of ERVs [72].